
50% of people with #ALS #MND die within 2 years of first symptoms. Riluzole improves survival by about 35% and is the only licensed disease-modifying therapy for this condition in the UK. Riluzole must be made available for people living with ALS / MND. theguardian.com/society/2024/j…

























